Unknown

Dataset Information

Efficacy and safety of berberine plus 5-ASA for ulcerative colitis: A systematic review and meta-analysis.


ABSTRACT:

Purpose

This study aimed to assess the efficacy and safety of berberine(BBR) plus 5-aminosalicylic acid (5-ASA) for treating ulcerative colitis (UC).

Methods

A comprehensive search was conducted in electronic databases, including Medline/PubMed, Sinomed, Embase, CNKI, Wanfang, and VIP, through January 2024 to identify all randomized controlled trials (RCTs) that administered BBR conjunction in standard therapy(5-ASA) for to support the treatment of UC. The data were synthesized using a meta-analysis approach with RevMan 5.4.1. The primary endpoint was the clinical efficacy rate. In contrast, the secondary endpoints included the Baron score, disease activity index (DAI) score, symptom relief latency, inflammatory markers, immunological indicators, and adverse events.

Resul

SUBMITTER: Li J 

PROVIDER: S-EPMC11379390 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature